United States · Bill · HR
H.R. 1720 (117th)
COVID–19 Medical Production Act
Introduced
9 March 2021
Last action
—
Status
Referred to the House Committee on Financial Services.
Sponsors
—
Subjects
Discovery layer
Source updated
15 May 2025
Summary
COVID-19 Medical Production Act This bill provides additional funding for FY2021 to acquire medical supplies, vaccines, and other equipment to combat COVID-19 (i.e., coronavirus disease 2019) using authorities under the Defense Production Act of 1950. That act confers on the President a broad set of authorities to influence domestic industry to provide essential materials and goods for the national defense. This funding is available through FY2025. Beginning in FY2023, it may be used to meet public health needs to address any pathogen determined by the President to have the potential to create a public health emergency.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 9 March 2021
Introduced in House (PDF)
Introduced in House · EN · 9 March 2021
Introduced in House
summary · EN · 9 March 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/1720
- Open data entity: https://api.congress.gov/v3/bill/117/hr/1720